Alnylam files patent infringement lawsuits against Pfizer, Moderna

  • 📰 Reuters
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 97%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

Alnylam Pharmaceuticals Inc on Thursday filed lawsuits in Delaware federal court against Pfizer Inc and Moderna Inc , claiming their multibillion-dollar mRNA COVID-19 vaccines infringe one its patents.

The U.S. National Institutes of Health has also implied it may sue Moderna over a vaccine-related patent application that NIH says should have listed its scientists as co-inventors.

Alnylam asked the court for an undisclosed amount of money damages from Pfizer and Moderna. It said in a statement it does not intend to take action that impedes the production, sale or distribution of the vaccines. Moderna has said its vaccine earned the company $17.7 billion in revenue in 2021. Pfizer said last month that it expected $32 billion in revenue from its vaccine this year.Reporting by Manojna Maddipatla in Bengaluru and Blake Brittain in Washington, D.C.; Editing by David Bario and Bill BerkrotSign up to our legal newsletter for a smart look at the day's headlines concerning the practice of law.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in LAW

Law Law Latest News, Law Law Headlines